Steroids in pediatric eosinophilic esophagitis
| dc.contributor.author | Contreras, Emily M. | |
| dc.contributor.author | Gupta, Sandeep K. | |
| dc.contributor.department | Pediatrics, School of Medicine | en_US |
| dc.date.accessioned | 2019-09-03T18:47:22Z | |
| dc.date.available | 2019-09-03T18:47:22Z | |
| dc.date.issued | 2014-06 | |
| dc.description.abstract | Swallowed fluticasone and oral viscous budesonide are effective first-line therapies for eosinophilic esophagitis in children. Side effects are minimal without evidence of Cushing syndrome, as seen in treatment with systemic corticosteroids. New studies on alternative delivery systems and different corticosteroids (eg, ciclesonide) are encouraging. As knowledge of corticosteroids in eosinophilic esophagitis expands, newer questions continue to arise concerning dose, delivery, and choice of corticosteroids; long-term adverse effects; and maintenance therapies. | en_US |
| dc.eprint.version | Author's manuscript | en_US |
| dc.identifier.citation | Contreras, E. M., & Gupta, S. K. (2014). Steroids in pediatric eosinophilic esophagitis. Gastroenterology clinics of North America, 43(2), 345–356. doi:10.1016/j.gtc.2014.02.008 | en_US |
| dc.identifier.uri | https://hdl.handle.net/1805/20756 | |
| dc.language.iso | en_US | en_US |
| dc.publisher | Elsevier | en_US |
| dc.relation.isversionof | 10.1016/j.gtc.2014.02.008 | en_US |
| dc.relation.journal | Gastroenterology Clinics of North America | en_US |
| dc.rights | Publisher Policy | en_US |
| dc.source | PMC | en_US |
| dc.subject | Budesonide | en_US |
| dc.subject | Children | en_US |
| dc.subject | Ciclesonide | en_US |
| dc.subject | Eosinophilic esophagitis | en_US |
| dc.subject | Fluticasone | en_US |
| dc.subject | Steroids | en_US |
| dc.subject | Topical steroids | en_US |
| dc.title | Steroids in pediatric eosinophilic esophagitis | en_US |
| dc.type | Article | en_US |